Experienced leader with decades in corporate strategy, business development, line management, scientific research, and market intelligence

Managed full life cycles of 20+ complex corporate development initiatives (Kimberly-Clark Healthcare, Halyard Health, Avanos Medical)

Business advisor for NIH/VA C3i Program, oversight committee member for Biolocity Fund, and founder of growth advisory consulting firm

Co-founder of four biotech companies: 1 commercial, 1 in clinical trials, 2 in pre-clinical

Hunter Endowed Chair & Professor of Bioengineering at Clemson University; Director of NIH-funded SC BioCRAFT Center

Pioneer in cardiovascular biomaterials; developed clinically used heart valve calcification treatments

Fellow of AIMBE with 25+ years of continuous NIH funding

Prolific innovator with 150+ publications, 15+ patents, and mentorship of 40+ graduate students

30 years’ experience developing biocompatible products with multinational companies and governments. Co-developed ISO and other global standards 

Former founding CEO of ICTV; former MD of EPEA Scientific Institute; Co-founder of O Instituto Ambientale, Brazil

Bestselling author on calcification and elastin. Researcher affiliated with 4 universities; currently at Technical University of Munich with 350+ citations

International leader in OCT-guided coronary interventions; validated OCT with histopathology for stent-vessel assessment.

Former President, Italian Society of Invasive Cardiology; Co-Chair, EAPCI Scientific Program for ESC Congress; Fellow, European Society of Cardiology since 2004.

Author of 300+ peer-reviewed manuscripts.

Lead author on expert consensus documents for intracoronary imaging; standardized OCT terminology and protocols for clinical practice.

Honorary Professor at Harbin Medical University; recipient of Italian Society of Interventional Cardiology Career Award (2022).

Distinguished Clinical Leadership: Co-Director of Prisma Health Aortic Center, leading multidisciplinary care for complex aortic pathologies and endovascular interventions.

Clinical Associate Professor (Vascular Surgery, USC SOM Greenville) and Clinical Assistant Professor (Biomedical Engineering, Clemson),.

Author of 20+ peer-reviewed publications.

 Certified by American Board of Surgery (General & Vascular), Fellow of the American College of Surgeons, Registered Physician in Vascular Interpretation (RPVI).

PhD in Biomedical Sciences (molecular neuroscience) and an MD.

Board-certified General Surgeon; completing specialized fellowship in Vascular Surgery at Prisma Health.

Authored multiple publications,  research spans molecular signaling, breast cancer therapy, and COVID-19-related thromboembolic events

Career includes NIH research grants, Southern Association of Vascular Surgery "Top Gun" Award, induction into Alpha Omega Alpha Honor Medical Society, and service as Conference Chair for Gordon Research Seminar

Non-clinical development expert with extensive experience in design and management of preclinical programs integrating research, pharmacology, ADME and toxicology. Broad expertise in early drug development ranging from small molecules to biologics, vaccines to ATMPs.

Today director of The NCD Company that provides non-clinical drug development services to the pharmaceutical industry.

 PhD from the Ludwig-Maximilians-University Munich. Led a full service non-clinical CRO for Pharmacology, ADME, Bioanalytics and Toxicology. 

President and Chief Scientific Officer at CVPath Institute since 2024.

Former Assistant Professor of Medicine at Emory University, directing NIH- and AHA-funded basic and translational cardiovascular research

Author of 100+ peer-reviewed articles, editorials, and reviews impacting cardiovascular science and clinical medicine

Editorial board member for Coronary Artery Disease and Arteriosclerosis, Thrombosis, and Vascular Biology, contributing to vascular research discourse

Emeritus Professor of Surgery & Vascular Medicine at USC School of Medicine Greenville; Founder of Gray Vascular LLC

Former Director of Endovascular Services at Prisma Health.

Editorial boards member of Annals of Vascular Surgery, Endovascular Today.

Past President, American Board of Vascular Medicine; Co-Chair of SCAI’s Peripheral Disease Committee.

Author of 160+ peer-reviewed articles 

Certified in Internal Medicine, Vascular Medicine, Endovascular Medicine.